Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology

We developed clinical practice guidelines to assess the individual risk-benefit profile of androgen replacement therapy in adult male hypogonadism (HG), defined by the presence of specific signs and symptoms and serum testosterone (T) below 12 nmol/L.